SAVR Procedure Tied to Higher Risk in Seniors
By HospiMedica International staff writers Posted on 12 Apr 2018 |
Elderly patients who undergo a surgical aortic valve replacement (SAVR) procedure suffer a considerably higher mortality rate, according to a new study.
Researchers at Université Laval (Quebec City, Canada) conducted a study in 672 consecutive, unselected SAVR patients (mean age 72 years, 61.5% male) undergoing SAVR in order to appraise long-term clinical outcomes, with a focus on structural valve degeneration (SVD), which the researchers defined as an increase in sub-clinical or clinical transvalvular pressure gradient, a decrease in valve area, and/or new-onset aortic regurgitation, as based on echocardiographic criteria. All patients were followed for a median time of 10 years.
The results revealed that 432 of the patients (64.3%) died during the study. Older age, left ventricular dysfunction, atrial fibrillation (AF), chronic obstructive pulmonary disease (COPD), greater body mass index (BMI), and diabetes mellitus were associated with an increased mortality risk. Clinically relevant SVD occurred in 6.6% of patients, but 30.1% had subclinical SVD. A specific aortic bioprosthesis was independently associated with clinically relevant SVD, resulting in 83% undergoing reintervention. The study was published in the April 3, 2018, issue of the Journal of the American College of Cardiology.
“The 10-year mortality rate in elderly SAVR recipients of a bioprosthetic valve was considerable, chiefly determined by their older age and the presence of comorbidities,” concluded lead author Tania Rodriguez-Gabella, MD. “These results provide contemporary data on long-term clinical outcomes and SVD post-SAVR, and they should be taken into consideration when evaluating late clinical outcomes and valve durability after transcatheter aortic valve replacement.”
Current guidelines recommend either transcatheter aortic valve implantation (TAVI) or SAVR in patients at high surgical risk, but suggest SAVR over TAVI for lower risk patients. Despite this recommendation, TAVI is becoming an increasingly popular alternative to open surgery, as it does not require thoracotomy or a heart-lung machine. TAVI involves a percutaneous intervention (PCI) via a catheter containing the replacement valve through the groin or chest; the new valve is pushed into the correct site where the surgeon expands it into position.
Related Links:
Université Laval
Researchers at Université Laval (Quebec City, Canada) conducted a study in 672 consecutive, unselected SAVR patients (mean age 72 years, 61.5% male) undergoing SAVR in order to appraise long-term clinical outcomes, with a focus on structural valve degeneration (SVD), which the researchers defined as an increase in sub-clinical or clinical transvalvular pressure gradient, a decrease in valve area, and/or new-onset aortic regurgitation, as based on echocardiographic criteria. All patients were followed for a median time of 10 years.
The results revealed that 432 of the patients (64.3%) died during the study. Older age, left ventricular dysfunction, atrial fibrillation (AF), chronic obstructive pulmonary disease (COPD), greater body mass index (BMI), and diabetes mellitus were associated with an increased mortality risk. Clinically relevant SVD occurred in 6.6% of patients, but 30.1% had subclinical SVD. A specific aortic bioprosthesis was independently associated with clinically relevant SVD, resulting in 83% undergoing reintervention. The study was published in the April 3, 2018, issue of the Journal of the American College of Cardiology.
“The 10-year mortality rate in elderly SAVR recipients of a bioprosthetic valve was considerable, chiefly determined by their older age and the presence of comorbidities,” concluded lead author Tania Rodriguez-Gabella, MD. “These results provide contemporary data on long-term clinical outcomes and SVD post-SAVR, and they should be taken into consideration when evaluating late clinical outcomes and valve durability after transcatheter aortic valve replacement.”
Current guidelines recommend either transcatheter aortic valve implantation (TAVI) or SAVR in patients at high surgical risk, but suggest SAVR over TAVI for lower risk patients. Despite this recommendation, TAVI is becoming an increasingly popular alternative to open surgery, as it does not require thoracotomy or a heart-lung machine. TAVI involves a percutaneous intervention (PCI) via a catheter containing the replacement valve through the groin or chest; the new valve is pushed into the correct site where the surgeon expands it into position.
Related Links:
Université Laval
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Latest Surgical Techniques News
- Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health
- Tiny Robots Made Out Of Carbon Could Conduct Colonoscopy, Pelvic Exam or Blood Test
- Miniaturized Ultrasonic Scalpel Enables Faster and Safer Robotic-Assisted Surgery
- AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy Detects More Lesions
- First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
- Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery